AU2001258106A1 - Lipid carrier compositions for improved drug retention - Google Patents
Lipid carrier compositions for improved drug retentionInfo
- Publication number
- AU2001258106A1 AU2001258106A1 AU2001258106A AU5810601A AU2001258106A1 AU 2001258106 A1 AU2001258106 A1 AU 2001258106A1 AU 2001258106 A AU2001258106 A AU 2001258106A AU 5810601 A AU5810601 A AU 5810601A AU 2001258106 A1 AU2001258106 A1 AU 2001258106A1
- Authority
- AU
- Australia
- Prior art keywords
- lipid carrier
- improved drug
- carrier compositions
- drug retention
- retention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 150000002632 lipids Chemical class 0.000 title 1
- 230000014759 maintenance of location Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20339900P | 2000-05-11 | 2000-05-11 | |
| US60203399 | 2000-05-11 | ||
| PCT/CA2001/000655 WO2001085131A2 (en) | 2000-05-11 | 2001-05-11 | Lipid carrier compositions for improved drug retention |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001258106A1 true AU2001258106A1 (en) | 2001-11-20 |
Family
ID=22753830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001258106A Abandoned AU2001258106A1 (en) | 2000-05-11 | 2001-05-11 | Lipid carrier compositions for improved drug retention |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001258106A1 (en) |
| WO (1) | WO2001085131A2 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002331481B2 (en) | 2001-10-03 | 2008-04-24 | Celator Pharmaceuticals, Inc. | Liposome loading with metal ions |
| US20060193902A1 (en) * | 2003-04-02 | 2006-08-31 | Celator Pharmaceuticals, Inc. | Pharmaceutical compositions containing active agents having a lactone group and transition metal ions |
| EP1796729A4 (en) * | 2004-10-06 | 2010-12-08 | Bc Cancer Agency | LIPOSOME WITH IMPROVED ARZNE RETENTION FOR THE TREATMENT OF CANCER |
| AU2005304914B2 (en) | 2004-11-05 | 2012-02-16 | Tekmira Pharmaceuticals Corporation | Compositions and methods for stabilizing liposomal camptothecin formulations |
| EA201070296A1 (en) * | 2007-08-21 | 2010-08-30 | Алза Корпорейшн | LIPOSOMIC COMPOSITIONS FOR THE INTRODUCTION IN VIVO OF BORONIC ACID CONNECTIONS |
| US10980798B2 (en) | 2011-11-03 | 2021-04-20 | Taiwan Liposome Company, Ltd. | Pharmaceutical compositions of hydrophobic camptothecin derivatives |
| US10391056B2 (en) | 2011-11-03 | 2019-08-27 | Taiwan Lipsome Company, LTD. | Pharmaceutical compositions of hydrophobic camptothecin derivatives |
| WO2014054026A1 (en) * | 2012-10-04 | 2014-04-10 | University Of The Witwatersrand, Johannesburg | Liposomal drug delivery system |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843473A (en) * | 1989-10-20 | 1998-12-01 | Sequus Pharmaceuticals, Inc. | Method of treatment of infected tissues |
| US5013556A (en) * | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5997899A (en) * | 1996-10-01 | 1999-12-07 | Skyepharma Inc. | Method for producing liposomes with increased percent of compound encapsulated |
| US5827533A (en) * | 1997-02-06 | 1998-10-27 | Duke University | Liposomes containing active agents aggregated with lipid surfactants |
| CA2346879A1 (en) * | 1998-09-16 | 2000-04-27 | Alza Corporation | Liposome-entrapped topoisomerase inhibitors |
-
2001
- 2001-05-11 WO PCT/CA2001/000655 patent/WO2001085131A2/en not_active Ceased
- 2001-05-11 AU AU2001258106A patent/AU2001258106A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001085131A3 (en) | 2002-04-25 |
| WO2001085131A2 (en) | 2001-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU781269C (en) | Pharmaceutical compositions | |
| AU2002340669A1 (en) | Lipid carrier compositions with enhanced blood stability | |
| AU2001250420A1 (en) | Pharmaceutical compositions | |
| AU2001274307A1 (en) | Pharmaceutical compositions | |
| EG24225A (en) | Solid lipid formulations | |
| AU3556400A (en) | Pharmaceutical compositions | |
| AU761544C (en) | Medicinal compositions containing anti-Fas antibody | |
| AU6715600A (en) | Pharmaceutical formulations | |
| AU2001273919A1 (en) | Pharmaceutical compositions | |
| AU2792700A (en) | Pharmaceutical composition containing cyclosporin | |
| HUP0201644A3 (en) | Liposome compositions for improved drug retention | |
| PL358616A1 (en) | Lipid carrier | |
| AU6460400A (en) | Pharmaceutical compositions | |
| AU7937500A (en) | Pharmaceutical composition containing midazolam | |
| AU2001258106A1 (en) | Lipid carrier compositions for improved drug retention | |
| AU4977300A (en) | Pharmaceutical formulations | |
| AU8832301A (en) | Pharmaceutical composition having modified carrier | |
| HUP0202652A3 (en) | Pharmaceutical carrier composition | |
| AU6460200A (en) | Pharmaceutical compositions | |
| AU4822500A (en) | Novel highly lipophilic camptothecin analogs | |
| AU2001291691A1 (en) | Drugs for incontinence | |
| AU1385801A (en) | Pharmaceutical formulations | |
| AU2001245867A1 (en) | Creatine containing caramel | |
| AU4085201A (en) | Pharmaceutical composition | |
| AU2002211005A1 (en) | Lipid peroxide-lowering compositions |